Cardiff Oncology
CRDF
66 hedge funds and large institutions have $56.3M invested in Cardiff Oncology in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 7 closing their positions.
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
66% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $1.15M
50% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 14
10% more funds holding
Funds holding: 60 → 66 (+6)
5% less capital invested
Capital invested by funds: $59.4M → $56.3M (-$3.01M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$2.05M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$474K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
+$420K |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$373K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$371K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$3.13M |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$990K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$607K |
| 4 |
Millennium Management
New York
|
-$284K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$217K |
CRDF Hedge Fund Activity: Q4 2015 in Review
66 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2015, worth a combined $56.3M — down 5.1% from $59.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CRDF positions and 7 closed out — a net gain of 6 holders — while 21 added to existing stakes and 14 trimmed.
The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $2.05M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $3.13M sold.
- 66 institutional investors held Cardiff Oncology (CRDF) as of Q4 2015, up from 60 in Q3 2015.
- Funds reported $56.3M of Cardiff Oncology stock for Q4 2015, down 5.1% quarter-over-quarter.
- 13 funds opened new Cardiff Oncology positions in Q4 2015 and 7 closed out, a net change of +6 holders.
- The largest Cardiff Oncology buyer in Q4 2015 was First Eagle Investment Management, an estimated $2.05M added.
- The largest Cardiff Oncology seller in Q4 2015 was Tekla Capital Management, an estimated $3.13M sold.
Based on aggregated 13F filings for Q4 2015.